Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.58 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1388796 | 0.86 | MCL1 (0.66) | EGFRKDM4EALDH1A1HPGDERBB2 | |
| SCHEMBL26081116 | 0.86 | KDM4E (0.71) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL1388797 | 0.86 | MCL1 (0.66) | EGFRKDM4EALDH1A1HPGDERBB2 | |
| SCHEMBL30856935 | 0.86 | MCL1 (0.66) | EGFRKDM4EALDH1A1HPGDERBB2 | |
| SCHEMBL29899054 | 0.84 | SLC16A3 (0.58) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL12673120 | 0.84 | SLC16A3 (0.55) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL26081115 | 0.84 | EGFR (0.59) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL19068202 | 0.84 | EGFR (0.59) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL15431185 | 0.83 | KDM4E (0.59) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL21470204 | 0.82 | ALDH1A1 (0.55) | KDM4EALDH1A1HPGDSLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230314934-A1 | PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-10-05 | — | — | US | disclosed |
| EP-3601609-A1 | ARTICLES AND METHODS INVOLVING DETECTION OF BINDING | Samdi Tech, Inc. (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2019196714-A1 | N-SUBSTITUTED ACRYLAMIDE DERIVATIVE AS DHODH INHIBITOR, AND PREPARATION AND USE THEREOF | 华东理工大学 | 2019-10-17 | — | — | WO | disclosed |
| WO-2018183482-A1 | ARTICLES AND METHODS INVOLVING DETECTION OF BINDING | SAMDI TECH, INC. (US) | 2018-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230314934-A1 | PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | CRY1, CBR3, C1S | EGFR 406/4885KDM4E 3165/4885CISD1 620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.